[
    {
        "oncogenic": "Oncogenic",
        "drugDescription": "This assertion is supported by (PMID: 25412846, 25952993).",
        "cancerTypes": [
            {
                "id": 418,
                "subtype": "Therapy-Related Myeloid Neoplasms",
                "code": "TMN",
                "color": "LightSalmon",
                "mainType": "Leukemia",
                "level": 4,
                "tissue": "Myeloid",
                "tumorForm": "LIQUID"
            }
        ],
        "excludedCancerTypes": [],
        "variant": {
            "gene": {
                "entrezGeneId": 7157,
                "hugoSymbol": "TP53",
                "grch37Isoform": "ENST00000269305",
                "grch37RefSeq": "NM_000546.5",
                "grch38Isoform": "ENST00000269305",
                "grch38RefSeq": "NM_000546.5",
                "geneAliases": [
                    "LFS1",
                    "p53"
                ],
                "genesets": [],
                "geneType": "TSG"
            },
            "consequence": {
                "term": "NA",
                "isGenerallyTruncating": false,
                "description": "NA"
            },
            "alteration": "Oncogenic Mutations",
            "name": "Oncogenic Mutations",
            "refResidues": null,
            "proteinStart": -1,
            "proteinEnd": 100000,
            "variantResidues": null,
            "referenceGenomes": [
                "GRCh38",
                "GRCh37"
            ]
        },
        "level": "Px1",
        "fdaLevel": null,
        "drug": [],
        "drugPmids": [
            "25412846",
            "25952993"
        ],
        "drugAbstracts": []
    },
    {
        "oncogenic": "Oncogenic",
        "drugDescription": "This assertion is supported by (PMID: 28819011, 26022239, 24684350, 8639789, 7579380).",
        "cancerTypes": [
            {
                "id": 586,
                "subtype": "Mantle Cell Lymphoma",
                "code": "MCL",
                "color": "LimeGreen",
                "mainType": "Mature B-Cell Neoplasms",
                "level": 5,
                "tissue": "Lymphoid",
                "tumorForm": "LIQUID"
            }
        ],
        "excludedCancerTypes": [],
        "variant": {
            "gene": {
                "entrezGeneId": 7157,
                "hugoSymbol": "TP53",
                "grch37Isoform": "ENST00000269305",
                "grch37RefSeq": "NM_000546.5",
                "grch38Isoform": "ENST00000269305",
                "grch38RefSeq": "NM_000546.5",
                "geneAliases": [
                    "LFS1",
                    "p53"
                ],
                "genesets": [],
                "geneType": "TSG"
            },
            "consequence": {
                "term": "NA",
                "isGenerallyTruncating": false,
                "description": "NA"
            },
            "alteration": "Oncogenic Mutations",
            "name": "Oncogenic Mutations",
            "refResidues": null,
            "proteinStart": -1,
            "proteinEnd": 100000,
            "variantResidues": null,
            "referenceGenomes": [
                "GRCh38",
                "GRCh37"
            ]
        },
        "level": "Px3",
        "fdaLevel": null,
        "drug": [],
        "drugPmids": [
            "7579380",
            "28819011",
            "26022239",
            "8639789",
            "24684350"
        ],
        "drugAbstracts": []
    },
    {
        "oncogenic": "Oncogenic",
        "drugDescription": "This assertion is supported by (PMID: 25860933, 25412851).",
        "cancerTypes": [
            {
                "id": 17,
                "subtype": "AML with Myelodysplasia-Related Changes",
                "code": "AMLMRC",
                "color": "LightSalmon",
                "mainType": "Leukemia",
                "level": 4,
                "tissue": "Myeloid",
                "tumorForm": "LIQUID"
            }
        ],
        "excludedCancerTypes": [],
        "variant": {
            "gene": {
                "entrezGeneId": 7157,
                "hugoSymbol": "TP53",
                "grch37Isoform": "ENST00000269305",
                "grch37RefSeq": "NM_000546.5",
                "grch38Isoform": "ENST00000269305",
                "grch38RefSeq": "NM_000546.5",
                "geneAliases": [
                    "LFS1",
                    "p53"
                ],
                "genesets": [],
                "geneType": "TSG"
            },
            "consequence": {
                "term": "NA",
                "isGenerallyTruncating": false,
                "description": "NA"
            },
            "alteration": "Oncogenic Mutations",
            "name": "Oncogenic Mutations",
            "refResidues": null,
            "proteinStart": -1,
            "proteinEnd": 100000,
            "variantResidues": null,
            "referenceGenomes": [
                "GRCh38",
                "GRCh37"
            ]
        },
        "level": "Px1",
        "fdaLevel": null,
        "drug": [],
        "drugPmids": [
            "25412851",
            "25860933"
        ],
        "drugAbstracts": []
    },
    {
        "oncogenic": "Oncogenic",
        "drugDescription": "This assertion is supported by (PMID: 19188171, 20697090, 24652989, 23243274, 24004666).",
        "cancerTypes": [
            {
                "id": 533,
                "subtype": "Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma",
                "code": "CLLSLL",
                "color": "LimeGreen",
                "mainType": "Mature B-Cell Neoplasms",
                "level": 5,
                "tissue": "Lymphoid",
                "tumorForm": "LIQUID"
            }
        ],
        "excludedCancerTypes": [],
        "variant": {
            "gene": {
                "entrezGeneId": 7157,
                "hugoSymbol": "TP53",
                "grch37Isoform": "ENST00000269305",
                "grch37RefSeq": "NM_000546.5",
                "grch38Isoform": "ENST00000269305",
                "grch38RefSeq": "NM_000546.5",
                "geneAliases": [
                    "LFS1",
                    "p53"
                ],
                "genesets": [],
                "geneType": "TSG"
            },
            "consequence": {
                "term": "NA",
                "isGenerallyTruncating": false,
                "description": "NA"
            },
            "alteration": "Oncogenic Mutations",
            "name": "Oncogenic Mutations",
            "refResidues": null,
            "proteinStart": -1,
            "proteinEnd": 100000,
            "variantResidues": null,
            "referenceGenomes": [
                "GRCh38",
                "GRCh37"
            ]
        },
        "level": "Px1",
        "fdaLevel": null,
        "drug": [],
        "drugPmids": [
            "23243274",
            "24004666",
            "20697090",
            "19188171",
            "24652989"
        ],
        "drugAbstracts": []
    },
    {
        "oncogenic": "Likely Oncogenic",
        "drugDescription": "This assertion is supported by (PMID: 9680348, 18337559, 17209057 Abstract: Hofste op Bruinink, D. et al. Abstract# Blood 128:3271, 2017. http://www.bloodjournal.org/content/128/22/3271?sso-checked=true; http://www.bloodjournal.org/content/122/21/1846).",
        "cancerTypes": [
            {
                "id": 645,
                "subtype": "Plasma Cell Myeloma",
                "code": "PCM",
                "color": "LimeGreen",
                "mainType": "Mature B-Cell Neoplasms",
                "level": 5,
                "tissue": "Lymphoid",
                "tumorForm": "LIQUID"
            }
        ],
        "excludedCancerTypes": [],
        "variant": {
            "gene": {
                "entrezGeneId": 7157,
                "hugoSymbol": "TP53",
                "grch37Isoform": "ENST00000269305",
                "grch37RefSeq": "NM_000546.5",
                "grch38Isoform": "ENST00000269305",
                "grch38RefSeq": "NM_000546.5",
                "geneAliases": [
                    "LFS1",
                    "p53"
                ],
                "genesets": [],
                "geneType": "TSG"
            },
            "consequence": {
                "term": "NA",
                "isGenerallyTruncating": false,
                "description": "NA"
            },
            "alteration": "Deletion",
            "name": "Deletion",
            "refResidues": null,
            "proteinStart": -1,
            "proteinEnd": 100000,
            "variantResidues": null,
            "referenceGenomes": [
                "GRCh38",
                "GRCh37"
            ]
        },
        "level": "Px1",
        "fdaLevel": null,
        "drug": [],
        "drugPmids": [
            "9680348",
            "17209057",
            "18337559"
        ],
        "drugAbstracts": [
            {
                "link": "http://www.bloodjournal.org/content/128/22/3271?sso-checked=true",
                "abstract": "Hofste op Bruinink, D. et al. Abstract# Blood 128:3271, 2017"
            }
        ]
    },
    {
        "oncogenic": "Oncogenic",
        "drugDescription": "This assertion is supported by (PMID: 22186996, 18596741).",
        "cancerTypes": [
            {
                "id": 527,
                "subtype": "Acute Myeloid Leukemia",
                "code": "AML",
                "color": "LightSalmon",
                "mainType": "Leukemia",
                "level": 3,
                "tissue": "Myeloid",
                "tumorForm": "LIQUID"
            }
        ],
        "excludedCancerTypes": [],
        "variant": {
            "gene": {
                "entrezGeneId": 7157,
                "hugoSymbol": "TP53",
                "grch37Isoform": "ENST00000269305",
                "grch37RefSeq": "NM_000546.5",
                "grch38Isoform": "ENST00000269305",
                "grch38RefSeq": "NM_000546.5",
                "geneAliases": [
                    "LFS1",
                    "p53"
                ],
                "genesets": [],
                "geneType": "TSG"
            },
            "consequence": {
                "term": "NA",
                "isGenerallyTruncating": false,
                "description": "NA"
            },
            "alteration": "Oncogenic Mutations",
            "name": "Oncogenic Mutations",
            "refResidues": null,
            "proteinStart": -1,
            "proteinEnd": 100000,
            "variantResidues": null,
            "referenceGenomes": [
                "GRCh38",
                "GRCh37"
            ]
        },
        "level": "Px1",
        "fdaLevel": null,
        "drug": [],
        "drugPmids": [
            "22186996",
            "18596741"
        ],
        "drugAbstracts": []
    },
    {
        "oncogenic": "Oncogenic",
        "drugDescription": "This assertion is supported by (PMID: 22887079, 29296692, 24478400).",
        "cancerTypes": [
            {
                "id": 695,
                "subtype": "Essential Thrombocythemia",
                "code": "ET",
                "color": "LightSalmon",
                "mainType": "Myeloproliferative Neoplasms",
                "level": 4,
                "tissue": "Myeloid",
                "tumorForm": "LIQUID"
            }
        ],
        "excludedCancerTypes": [],
        "variant": {
            "gene": {
                "entrezGeneId": 7157,
                "hugoSymbol": "TP53",
                "grch37Isoform": "ENST00000269305",
                "grch37RefSeq": "NM_000546.5",
                "grch38Isoform": "ENST00000269305",
                "grch38RefSeq": "NM_000546.5",
                "geneAliases": [
                    "LFS1",
                    "p53"
                ],
                "genesets": [],
                "geneType": "TSG"
            },
            "consequence": {
                "term": "NA",
                "isGenerallyTruncating": false,
                "description": "NA"
            },
            "alteration": "Oncogenic Mutations",
            "name": "Oncogenic Mutations",
            "refResidues": null,
            "proteinStart": -1,
            "proteinEnd": 100000,
            "variantResidues": null,
            "referenceGenomes": [
                "GRCh38",
                "GRCh37"
            ]
        },
        "level": "Px1",
        "fdaLevel": null,
        "drug": [],
        "drugPmids": [
            "29296692",
            "22887079",
            "24478400"
        ],
        "drugAbstracts": []
    },
    {
        "oncogenic": "Oncogenic",
        "drugDescription": "This assertion is supported by (PMID: 24220272, 21714648, 25092778).",
        "cancerTypes": [
            {
                "id": 355,
                "subtype": "Myelodysplastic Syndromes",
                "code": "MDS",
                "color": "LightSalmon",
                "mainType": "Myelodysplastic Syndromes",
                "level": 3,
                "tissue": "Myeloid",
                "tumorForm": "LIQUID"
            }
        ],
        "excludedCancerTypes": [],
        "variant": {
            "gene": {
                "entrezGeneId": 7157,
                "hugoSymbol": "TP53",
                "grch37Isoform": "ENST00000269305",
                "grch37RefSeq": "NM_000546.5",
                "grch38Isoform": "ENST00000269305",
                "grch38RefSeq": "NM_000546.5",
                "geneAliases": [
                    "LFS1",
                    "p53"
                ],
                "genesets": [],
                "geneType": "TSG"
            },
            "consequence": {
                "term": "NA",
                "isGenerallyTruncating": false,
                "description": "NA"
            },
            "alteration": "Oncogenic Mutations",
            "name": "Oncogenic Mutations",
            "refResidues": null,
            "proteinStart": -1,
            "proteinEnd": 100000,
            "variantResidues": null,
            "referenceGenomes": [
                "GRCh38",
                "GRCh37"
            ]
        },
        "level": "Px1",
        "fdaLevel": null,
        "drug": [],
        "drugPmids": [
            "24220272",
            "25092778",
            "21714648"
        ],
        "drugAbstracts": []
    },
    {
        "oncogenic": "Oncogenic",
        "drugDescription": "PC14586 is an orally available, small-molecule structural corrector specific for the Y220C-mutant p53 protein. In a phase I study of PC14586 in 29 patients with advanced solid tumors harboring a TP53 Y220C mutation, one patient with small cell lung cancer and one patient with breast cancer each had a partial response to treatment (Abstract: Dumbrava et al. Abstract# 3003, ASCO 2022. https://ascopubs.org/doi/abs/10.1200/JCO.2022.40.16_suppl.3003). In vivo xenograft studies with TP53 Y220C-mutant gastric cancer cell line NUGC3 and Y220C-mutant patient-derived xenografts demonstrated sensitivity to PC14586 treatment as measured by dose-dependent tumor shrinkage and conversion of TP53 Y220C to the wildtype conformation (Abstract: Dumble et al. Abstract# LB006, AACR 2021. https://aacrjournals.org/cancerres/article/81/13_Supplement/LB006/669897/Abstract-LB006-PC14586-The-first-orally).",
        "cancerTypes": [
            {
                "id": 984,
                "subtype": "",
                "code": "",
                "color": "",
                "mainType": "All Solid Tumors",
                "level": -1,
                "tissue": "",
                "tumorForm": "SOLID"
            }
        ],
        "excludedCancerTypes": [],
        "variant": {
            "gene": {
                "entrezGeneId": 7157,
                "hugoSymbol": "TP53",
                "grch37Isoform": "ENST00000269305",
                "grch37RefSeq": "NM_000546.5",
                "grch38Isoform": "ENST00000269305",
                "grch38RefSeq": "NM_000546.5",
                "geneAliases": [
                    "LFS1",
                    "p53"
                ],
                "genesets": [],
                "geneType": "TSG"
            },
            "consequence": {
                "term": "missense_variant",
                "isGenerallyTruncating": false,
                "description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"
            },
            "alteration": "Y220C",
            "name": "Y220C",
            "refResidues": "Y",
            "proteinStart": 220,
            "proteinEnd": 220,
            "variantResidues": "C",
            "referenceGenomes": [
                "GRCh38",
                "GRCh37"
            ]
        },
        "level": "3A",
        "fdaLevel": "Fda3",
        "drug": [
            "PC14586"
        ],
        "drugPmids": [],
        "drugAbstracts": [
            {
                "link": "https://aacrjournals.org/cancerres/article/81/13_Supplement/LB006/669897/Abstract-LB006-PC14586-The-first-orally",
                "abstract": "Dumble et al. Abstract# LB006, AACR 2021"
            },
            {
                "link": "https://ascopubs.org/doi/abs/10.1200/JCO.2022.40.16_suppl.3003",
                "abstract": "Dumbrava et al. Abstract# 3003, ASCO 2022"
            }
        ]
    },
    {
        "oncogenic": "Oncogenic",
        "drugDescription": "This assertion is supported by (PMID: 22887079, 25516983, 22052707).",
        "cancerTypes": [
            {
                "id": 632,
                "subtype": "Primary Myelofibrosis",
                "code": "PMF",
                "color": "LightSalmon",
                "mainType": "Myeloproliferative Neoplasms",
                "level": 4,
                "tissue": "Myeloid",
                "tumorForm": "LIQUID"
            }
        ],
        "excludedCancerTypes": [],
        "variant": {
            "gene": {
                "entrezGeneId": 7157,
                "hugoSymbol": "TP53",
                "grch37Isoform": "ENST00000269305",
                "grch37RefSeq": "NM_000546.5",
                "grch38Isoform": "ENST00000269305",
                "grch38RefSeq": "NM_000546.5",
                "geneAliases": [
                    "LFS1",
                    "p53"
                ],
                "genesets": [],
                "geneType": "TSG"
            },
            "consequence": {
                "term": "NA",
                "isGenerallyTruncating": false,
                "description": "NA"
            },
            "alteration": "Oncogenic Mutations",
            "name": "Oncogenic Mutations",
            "refResidues": null,
            "proteinStart": -1,
            "proteinEnd": 100000,
            "variantResidues": null,
            "referenceGenomes": [
                "GRCh38",
                "GRCh37"
            ]
        },
        "level": "Px1",
        "fdaLevel": null,
        "drug": [],
        "drugPmids": [
            "22887079",
            "25516983",
            "22052707"
        ],
        "drugAbstracts": []
    },
    {
        "oncogenic": "Oncogenic",
        "drugDescription": "This assertion is supported by (PMID: 22887079, 25516983, 22052707).",
        "cancerTypes": [
            {
                "id": 185,
                "subtype": "Myeloproliferative Neoplasms",
                "code": "MPN",
                "color": "LightSalmon",
                "mainType": "Myeloproliferative Neoplasms",
                "level": 3,
                "tissue": "Myeloid",
                "tumorForm": "LIQUID"
            }
        ],
        "excludedCancerTypes": [],
        "variant": {
            "gene": {
                "entrezGeneId": 7157,
                "hugoSymbol": "TP53",
                "grch37Isoform": "ENST00000269305",
                "grch37RefSeq": "NM_000546.5",
                "grch38Isoform": "ENST00000269305",
                "grch38RefSeq": "NM_000546.5",
                "geneAliases": [
                    "LFS1",
                    "p53"
                ],
                "genesets": [],
                "geneType": "TSG"
            },
            "consequence": {
                "term": "NA",
                "isGenerallyTruncating": false,
                "description": "NA"
            },
            "alteration": "Oncogenic Mutations",
            "name": "Oncogenic Mutations",
            "refResidues": null,
            "proteinStart": -1,
            "proteinEnd": 100000,
            "variantResidues": null,
            "referenceGenomes": [
                "GRCh38",
                "GRCh37"
            ]
        },
        "level": "Px1",
        "fdaLevel": null,
        "drug": [],
        "drugPmids": [
            "22887079",
            "25516983",
            "22052707"
        ],
        "drugAbstracts": []
    }
]